Safety and efficacy of fecal microbiota transplantation from healthy volunteers for patients with primary sclerosing cholangitis
Not Applicable
- Conditions
- Primary sclerosing cholangitis
- Registration Number
- JPRN-UMIN000036121
- Lead Sponsor
- Keio University, School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with a decompensated cirrhosis (Child Pugh score upper 10 point)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The level of serum ALP at 1, 2, 4, 8, 12, and 24 weeks post FMT
- Secondary Outcome Measures
Name Time Method